Valuation : Adocia

Market Cap 78.19M 90.81M 73.41M 67.01M 126M 8.64B 127M 870M 338M 4.38B 341M 334M 14.51B P/E 2026 *
-729x
P/E 2027 * 5.78x
Enterprise Value 48.34M 56.15M 45.39M 41.43M 77.84M 5.34B 78.4M 538M 209M 2.71B 211M 206M 8.97B EV / Sales 2026 *
19.2x
EV / Sales 2027 * 3.06x
Free-Float
96.05%
Yield 2026 *
-
Yield 2027 * -
1 day-0.20%
1 week-1.77%
Current month+0.71%
1 month+0.71%
3 months-17.16%
6 months-35.88%
Current year-40.48%
1 week 3.94
Extreme 3.94
4.1
1 month 3.87
Extreme 3.866
4.3
Current year 3.61
Extreme 3.61
7.45
1 year 3.61
Extreme 3.61
12.4
3 years 2.86
Extreme 2.86
12.66
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
61.9
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 80 24/02/2012
Director/Board Member 58 18/06/2013
Date Insider Type Main position Quantity % Market Cap. Importance
2/27/25 A Buy

Founder

109,170 0.6972%
4/6/24 A Buy

Founder

15,576 0.1105%
4/6/24 A Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%-1.77%-49.71%-64.77% 90.73M
-1.66%-4.96%+49.84%+88.43% 69.54B
-2.19%+1.32%+44.54%+88.38% 64.97B
-3.57%-4.24%+47.11%+5.60% 26.51B
+1.89%-2.88%-17.13%+450.09% 25.89B
-0.96%-10.41%+0.46%-16.41% 25.64B
-9.71%-0.36%+245.87%+377.68% 20.22B
-1.58%+0.47%+29.35%-19.62% 19.98B
-3.36%-7.58%+9.47%+535.81% 15.69B
-0.10%-0.48%+46.02%+142.47% 13.49B
Average -2.14%-3.75%+40.58%+158.77% 28.2B
Weighted average by Cap. -2.16%-3.50%+47.87%+144.80%

Financials

2026 *2027 *
Net sales 2.52M 2.93M 2.37M 2.16M 4.06M 279M 4.09M 28.06M 10.92M 141M 11M 10.76M 468M 35.4M 41.11M 33.24M 30.34M 57M 3.91B 57.41M 394M 153M 1.98B 154M 151M 6.57B
Net income -4.32M -5.01M -4.05M -3.7M -6.95M -477M -7M -48.03M -18.69M -242M -18.83M -18.42M -801M -44.33M -51.48M -41.62M -37.99M -71.38M -4.9B -71.89M -493M -192M -2.48B -193M -189M -8.22B
Net Debt -29.84M -34.66M -28.02M -25.58M -48.05M -3.3B -48.4M -332M -129M -1.67B -130M -127M -5.54B 30.18M 35.05M 28.33M 25.86M 48.59M 3.33B 48.94M 336M 131M 1.69B 132M 129M 5.6B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
31/08/26 3.988 -0.20% 46,017
28/08/26 €3.996 -0.40% 31,732
27/08/26 €4.012 +0.80% 37,398
26/08/26 €3.980 -0.75% 90,232
25/08/26 €4.010 -1.23% 135,991
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.996EUR
Average target price
9.700EUR
Spread / Average Target
+142.74%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock